Background. Antimicrobial resistance especially caused by extended-spectrum β-lactamase-producing Enterobacteriaceae (ESBL-PE) has become a global public health concern. Globally, these isolates have remained the most important causes of several infections and associated mortality. Their rapid spread in Ethiopia is associated with a lack of regular surveillance and antibiotic stewardship programs. Isolates of ESBL-PE from different regions of Ethiopia were searched exhaustively. However, published data regarding the pooled estimate of ESBL-PE are not conducted in Ethiopia. For this reason, we systematically reviewed laboratory-based studies to summarize the overall pooled prevalence of the isolates recovered from various human specimens. Me...
A high proportion of Extended-Spectrum-Beta-Lactamase (ESBL) producing Enterobacteriaceae is causing...
BACKGROUND:The emergence of multidrug-resistance (MDR), production of extended-spectrum β-lactamases...
Melese Hailu Legese,1 Gebru Mulugeta Weldearegay,1 Daniel Asrat,2 1Department of Clinical Laboratory...
Background. Multidrug-resistant Enterobacteriaceae particularly extended-spectrum beta-lactamase pro...
Abstract Background The prevalence of extended-spectrum β-lactamases (ESBLs) have been reported in c...
BackgroundThe prevalence of extended-spectrum -lactamases (ESBLs) have been reported in clinical iso...
The treatment of invasive Escherichia coli infections is a challenge because of the emergence and ra...
The treatment of invasive Escherichia coli infections is a challenge because of the emergence and ra...
We investigated the gastrointestinal colonization rate and antibiotic resistance patterns of Extende...
The spread of Extended-Spectrum beta (β)-Lactamases (ESBL)-producing Enterobacteriaceae has become a...
Extended-spectrum beta-lactamases (ESBLs) and AmpC producing Enterobacteriaceae are public health th...
Introduction: Antibiotic resistances due to extended-spectrum β-lactamases (ESBLs), AmpCs and carbap...
Background. The world prevalence of community and hospital-acquired extended-spectrum β-lactamase (E...
BackgroundInfections caused by extended-spectrum beta-lactamases (ESBL) producing Gram-negative bact...
Extended-spectrum beta-lactamases (ESBLs) and AmpC producing Enterobacteriaceae are public health th...
A high proportion of Extended-Spectrum-Beta-Lactamase (ESBL) producing Enterobacteriaceae is causing...
BACKGROUND:The emergence of multidrug-resistance (MDR), production of extended-spectrum β-lactamases...
Melese Hailu Legese,1 Gebru Mulugeta Weldearegay,1 Daniel Asrat,2 1Department of Clinical Laboratory...
Background. Multidrug-resistant Enterobacteriaceae particularly extended-spectrum beta-lactamase pro...
Abstract Background The prevalence of extended-spectrum β-lactamases (ESBLs) have been reported in c...
BackgroundThe prevalence of extended-spectrum -lactamases (ESBLs) have been reported in clinical iso...
The treatment of invasive Escherichia coli infections is a challenge because of the emergence and ra...
The treatment of invasive Escherichia coli infections is a challenge because of the emergence and ra...
We investigated the gastrointestinal colonization rate and antibiotic resistance patterns of Extende...
The spread of Extended-Spectrum beta (β)-Lactamases (ESBL)-producing Enterobacteriaceae has become a...
Extended-spectrum beta-lactamases (ESBLs) and AmpC producing Enterobacteriaceae are public health th...
Introduction: Antibiotic resistances due to extended-spectrum β-lactamases (ESBLs), AmpCs and carbap...
Background. The world prevalence of community and hospital-acquired extended-spectrum β-lactamase (E...
BackgroundInfections caused by extended-spectrum beta-lactamases (ESBL) producing Gram-negative bact...
Extended-spectrum beta-lactamases (ESBLs) and AmpC producing Enterobacteriaceae are public health th...
A high proportion of Extended-Spectrum-Beta-Lactamase (ESBL) producing Enterobacteriaceae is causing...
BACKGROUND:The emergence of multidrug-resistance (MDR), production of extended-spectrum β-lactamases...
Melese Hailu Legese,1 Gebru Mulugeta Weldearegay,1 Daniel Asrat,2 1Department of Clinical Laboratory...